The ApogeeBio programme will propose 24 post-doctoral fellowships of 24 months within 3 international competitive calls. The objective of the programme, through such an ambitious joint action, is to foster the international attractiveness and visibility of the whole biocluster of Genopole, with the aim to attract high quality international researchers from Europe and all over the world. The fellows will be recruited in a world-class research and innovation environment with more than 2,400 people employed by 83 companies, 14 academic research laboratories, and 25 technology platforms and infrastructures. The ApogeeBio project cover interdisciplinary fields of research and innovation applied to health and environment. Through ApogeeBio, a higher level is reached compared to existing high-quality post-doctoral fellowship programmes in the biocluster. -Via an attractive position, including excellent working and research conditions, the programme will provide fellows with training and networking opportunities that will enhance their career development potential and boost the relevance of their work for other sectors within and outside academia, including regular interaction with private biotechs of the biocluster Genopole. -The ApogeeBio programme will not only rise the excellence of the biocluster and its research fellows but it will also help the implementation of European standards and stimulate adopting and sharing good practices to anchor the biolcuster Genopole as an active contributor to the ERA. The aim of ApogeeBio is also to support research excellence in Europe and favour the nurturing of highly-qualified researchers; it will help the fellows recruited to : - Develop Academic Independence - Enhance their Mobility profile by experiencing different environments, widening their perspectives, expanding their international networks, and gaining new opportunities for cross-sectoral and/or multidisciplinary collaborations - Boost career development

COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support. Specifically, the proposition will focus on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…). COBIOE will reach the following objectives: - Provide a state of the art and exploitable overview of the European bioproduction value chain, focusing on European, national, regional strategy or existing initiatives, activities - Opening up the bioproduction field, by reaching out to isolated actors and territories bringing added value to the chain. - Building up bridges between sparse innovative ecosystems and initiatives opening up opportunities for isolated players. - Promote bioproduction ecosystems, the field and its potentialities in terms of green, digital and social transition, among various stakeholders and policymakers COBIOE proposal includes 5 health clusters/networks, preeminent and pioneers in the field of pharmaceutical biomanufacturing. Each partner complements each other in terms of competence and the partnership covers almost all European regions from north to south and east to west, including modest, moderate, strong and leading innovators. Moreover, each partner benefits from an extended network of stakeholders, from different technological sectors (materials science, artificial intelligence, biotechnology, blockchain, robotics, photonics, electronics and quantum information) and actors (universities, research, hospitals, funders…).

In the coming decades, society faces the formidable challenge of providing sustenance for a global population expected to reach 10 billion by 2050. Fortunately, the burgeoning field of biotechnology holds significant promise in addressing this challenge by revolutionizing food production. The central aim of this proposal is to pave the way for the widespread adoption of an innovative technology known as cellular agriculture, which is poised to play a pivotal role in facilitating the global protein transition. Cellular agriculture, in essence, represents a breakthrough methodology for producing a spectrum of sustainable food products. Lead by 8 organisations from 7 countries, representing the innovation ecosystem, APROVALS aims to facilitate the seamless integration of emerging cellular agriculture technologies into the global food landscape, through two main activities: - Sandbox for Innovation: APROVALS offers a dedicated sandbox environment where innovators can test and refine their solutions. This sandbox acts as a fertile ground for experimentation, enabling startups and SMEs to develop their technologies and bring them to market. - Interconnected Stakeholders: The project places a strong emphasis on fostering collaboration among key stakeholders involved in cellular agriculture: 1) Start-ups and Growing SMEs: These enterprises are provided with essential support to advance their technologies and successfully navigate the journey from innovation to market. 2) Innovation Support: Tailored support initiatives are crafted to mitigate risks associated with the innovation process, fostering a conducive ecosystem for cellular agriculture innovation. 3) Regulators and Policymakers: APROVALS actively engages with regulators and policymakers to establish robust protocols and a legal framework. This framework serves to safeguard the market and consumers while simultaneously preventing unwarranted regulatory hurdles that could impede progress in cellular agriculture.